Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Gender-Affirming Hormone Therapy Among Transgender Women

NCT04128488 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04128488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04128488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Gender-Affirming Hormone Therapy Among Transgender Women
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Completed
Start date
November 1, 2019
Completion date
March 28, 2024
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, coagulopathy, hiv/aids, metabolic disease, transgender women